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Abstract Culture collections have the crucial role of
providing the authenticated biological material upon
which high quality research is based. Importantly, they
serve as repositories for strains as part of patent
deposits, providers of safe and conﬁdential services to
store key organisms for research and industry, and
sources of organisms cited in scientiﬁc papers that can be
used in the conﬁrmation of results and for further study.
The demands upon culture collections change as new
technologies and uses of organisms are discovered.
Many are becoming Biological Resource Centres, as
deﬁned by the OECD Biological Resource Centre (BRC)
Initiative, in that they operate according to international
quality criteria, carry out essential research, enhance the
value and applications of strains and provide a vital
information resource. In a changing international sci-
entiﬁc environment, many collections are under threat of
extinction because of inadequate funding, changing
government support strategies and the cost of new
technologies. We are also suﬀering a decline in the
number of biosystematists, who are needed to form a
sound base for molecular technologies and to aid in
identifying, and characterizing microbial diversity. In
this environment, collections must work together to
make the best use of new technologies and to contribute
to the description of the 1.4 million fungi yet to be dis-
covered. At the current rate, this will take 700 years.
New technologies and novel ways of funding this task
must be engaged and, above all, scientists must collab-
orate. Common policies are necessary to address the
regulatory demands on collections, to control access to
dangerous organisms, and, in particular, to enforce the
Convention on Biological Diversity. Countries that hold
the majority of biodiversity require support in building
the facilities required to explore their hidden resource.
The World Federation for Culture Collections (WFCC)
and, in Europe, the European Culture Collection
Organisation (ECCO) have a key role to play. The world
must beneﬁt from its microbial diversity, which is crucial
to solving increasing problems in food provision, public
health and poverty alleviation.
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Introduction
The tasks that face microbial culture collections are
enormous, whilst funding for them and the associated
biosystematics and fundamental research are on the
decline. There are estimated to be over 1.5 million fungi
in the world but less than 100,000 are described [5]. At
the current rate of discovery, it will take 700 years to
describe them all. However, there is also strain diversity
to be considered, making the potential numbers huge.
Genomics, post-genomics and other developing areas in
bioinformatics are placing enormous demands on
researchers and collections, making it imperative that
information generation and maintenance of ex situ
microbial diversity are coordinated and that tasks are
shared. The OECD Biological Resource Centre Initia-
tive is examining how collections can be networked to
form a global ‘virtual’ BRC and a proactive role is de-
ﬁned for them. Details on this initiative can be found in
the OECD report Biological Resource Centres—Under-
pinning the Future of Life Sciences and Biotechnology
[http://oecdpublications.gﬁ-nb.com/cgi-bin/oecdbookshop.
storefront].
It is recognized that microorganisms can provide
solutions to world problems in public health, food,
environment and poverty [8, 13, 15]. They are vital
components of the world’s biodiversity, contributing
immense value ecologically and economically. They are
fundamentally important in ecosystems, breaking down








complex animal and plant remains in soil and thus
releasing essential nutrients for plant growth; they form
beneﬁcial mutualistic relationships with various plants,
for example, nitrogen-ﬁxing rhizobia with leguminous
plants and mycorrhiza with forest trees; and they have
also been harnessed for the beneﬁt of humankind, pro-
ducing valuable drugs, being used as biocontrol agents
for pests and pathogens as well as in the detoxiﬁcation of
wastes and waste breakdown. It is thus crucial that the
microbial diversity of the world is not lost and that it is
identiﬁed, characterised and exploited in a sustainable
way for the beneﬁt of humankind.
The safeguarding of microbial diversity for future use
and exploitation is of vital importance for wealth crea-
tion. The potential for discovering the new penicillin or
ﬁnding organisms that have industrial uses is enormous.
However, this is not as easy as it ﬁrst looks and invest-
ment is necessary to discover such products. The chem-
icals and drugs currently on the market originating from
microorganisms are often the results of limited screen-
ing, and microbiologists can improve and accelerate the
search. CABI, an intergovernmental organization
[http://www.cabi.org], encompasses in its mission the
support of developing countries and in particular the 41
CABI member countries who own it. It has developed
marketable products that are generating income for
support of biodiversity initiatives, fundamental research,
biosystematics and collection development and mainte-
nance. Such examples can be followed to make best use
of the world’s hidden resource, its microorganisms.
Culture collections have an important role in providing
the biological resource to underpin research and devel-
opment. There is not one collection on its own that can
conserve representatives of all microorganisms, yet there
is little coordination of activities. Areas of the world rich
in biodiversity have few facilities for the ex situ conser-
vation that is essential for compliance with the require-
ments of the Convention on Biological Diversity (CBD)
and that enable them to take advantage of the potential
of microorganisms. Culture collection organizations,
such as the World Federation for Culture Collections
(WFCC) and the European Culture Collection Organi-
sation (ECCO), act as fora for discussion by bringing
together a critical mass of collections and users to try
and co-ordinate activities as well as to exchange infor-
mation and technologies that will facilitate progress in
this vital task.
The World Federation for Culture Collections
The WFCC was founded in 1963 and is a multidisci-
plinary commission of the International Union of Bio-
logical Sciences (IUBS). Since the separation of the
International Union of Microbiological Societies
(IUMS) from IUBS in 1979, it has operated as an inter-
union commission [http://www.wfcc.info] that seeks to
promote activities supporting the interests of culture
collections and their users. Member collections of the
WFCC register with the World Data Center for
Microorganisms (WDCM), and there are currently
approximately 470 member collections [13]. The WFCC
has a total membership of around 700 from 62 countries.
A congress is held every 4 years to discuss advances in
technology and common policies with regard to biodi-
versity and the role of culture collections. The WFCC
keeps its members informed on matters relevant to col-
lections in its newsletter and has standing committees
reporting on patent depositions; postal, quarantine and
safety regulations; the safeguarding of endangered col-
lections; education, publicity, standards and biodiver-
sity. Since 1986, the WFCC has overseen the activities of
the WDCM and it is now the data center for the WFCC
and Microbial Resource Centers (MIRCENs) Network.
Established in 1966, the WFCC produced the ﬁrst hard-
copy volume of the World Directory of Collections of
Cultures of Microorganisms, in 1972, whilst based at the
University of Queensland, Australia. The WDCM relo-
cated in 1986 to RIKEN, Saitama, Japan, and then
again in 1999 to the National Institute of Genetics,
Japan. The World Directory [13] illustrates some of the
data held on the Web site [http://wdcm.nig.ac.jp]; it has
indexes by country, main subjects studied, cultures held,
culture availability, their staﬀ, and services oﬀered. The
WDCM collections hold in excess of 1 million strains
(see distribution by continents in Table 1), 44% of
which, are fungi, 43% bacteria, 2% viruses, 1% live
cells, and 10% others (including plasmids, plants, ani-
mal cells and algae).
European Culture Collection Organisation
The European culture collections have collaborated to-
gether since 1982, when the European Culture Collec-
tion Curators Organisation was established to bring the
managers of the major public service collections in
Europe together to discuss common policy, exchange
technologies and seek collaborative projects. The orga-
nization opened itself to staﬀ and users of microorgan-
isms and is now named the European Culture Collection
Organisation (ECCO). There are currently 65 members,
including 57 collections that hold over 350,000 strains.
Members have helped produce practical approaches to
international rules and regulation. Initiatives led by the
Belgian Coordinated Collections of Microorganisms
(BCCM) have led to a code of practice for collections to
operate within the Budapest Treaty (1983) and the
Microorganisms, Sustainable Access and Use, Interna-
tional Code of Conduct (MOSAICC), which provides
guidelines for compliance with the CBD [http://
www.belspo.be/bccm/mosaicc]. There have been several
collaborative projects involving ECCO members that
have placed the European collections at the cutting edge
of culture collection activities and research. The most
recent, European Biological Resource Centre Network
(EBRCN), follows on from the Common Access to
Biological Resources and Information (CABRI)
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electronic catalogue project [http://www.cabri.org]. This
project is setting operational standards for the operation
of European biological resource centres and is working
in close collaboration with the OECD BRC initiative
and the WFCC. Information on the members, activities
and meetings can be accessed via the ECCO Web site
[http://www.eccosite.org].
Microbial diversity
Europe and America hold 56% of the collections and
71% of the microorganisms (Table 1), whereas most
diversity lies outside these regions. There are many
examples of biodiversity-rich countries and it is not
unreasonable to ﬁnd that 20–30% of isolations in
tropical and extreme environments are new to science.
Malaysia is one of the 12 countries of megadiversity that
together hold 60–70% of the world’s biodiversity, but
little is known about the microbial component. It has
12,500 known ﬂowering plants, and using Hawksworth’s
formula of an estimated six unique fungi per plant [5],
potentially 75,000 associated fungi. Yet there are only
ﬁve microbial collections registered with the WDCM
and together these hold 2,108 strains. Similarly, China
has a huge biodiversity. China ranks third behind
Malaysia and Brazil in numbers of species of plants
[http://www.biodiv.org]. The China National Reports
and Biodiversity Action Plan reveals that there are
83,000 species in total, excluding soil organisms,
microorganisms and insects. The country is a vast ter-
ritory of complex climates and very diverse geography,
with tropical forest covering only 0.5% of land but
holding 25% of China’s species. It is one of the largest
agricultural countries of the world with 30 species of
grain, 200 types of vegetables and 300 types of fruit
trees. The associated microbial diversity includes 8,000
species of fungi, 5,000 species of bacteria and 500 algae.
However, according to Hawksworth’s [5] formula, for
the 30,000 ﬂowering plants there are possibly 180,000
fungi and therefore some way to go to identify the
remainder. The Chinese microbial culture collections
have made some inroads into storing representatives of
the microﬂora: there are 14 collections registered with
the WDCM with some 30,000 strains of bacteria and
fungi and a total of 13,500 species held in ex situ col-
lections (Table 2).
Conservation of microorganisms
In addition to ex situ conservation, microorganisms can
be maintained in situ. However, it is diﬃcult to assess
the eﬀectiveness of in situ conservation when we have so
little information on the extent of microbial diversity.
Microorganisms are subject to relatively rapid evolution
and adapt and change to environmental factors that in
some cases can eliminate some of them. There are many
plants on the endangered species list but it is likely that
for every ﬂowering plant that is lost the six associated
species of fungi are lost, too. The application of modern
genomic techniques to assess microorganisms presents
problems, e.g. limited information [1] and the fact that
population genetics for fungal communities can be dif-
ﬁcult as DNA is not always easily released from the
fungal cell [2]. Additionally, WDCM data show that
50% of holdings are represented only in one collection.
It is not always possible to go back to a location and
isolate the same species with exactly the same properties.
There are so many threats to biodiversity, including
habitat loss, conversion of forests to farmland and the
over-exploitation of natural resources such as harvesting
lichens from rainforest. However, today it is more likely
that industrial pollution has the greatest eﬀect on
numbers of species.
BRCs have a role to play in the ex situ conservation
of organisms by providing a living resource to underpin
the life sciences [6]. They accept deposits subject to
publication to enable conﬁrmation of results and further
studies, and oﬀer safe, conﬁdential and patent deposit
services. BRCs not only supply strains but also provide
reference and standard strains along with the associated
information, and they carry out preservation research to
ensure that strains are preserved without change [12].
Organisms held by BRCS are necessary for teaching and
research and can provide microbial solutions for many
of today’s problems. Crop losses can be reduced by
integrated pest management programs that include the
use of natural enemies to control pests and diseases.
Crop wastes can be degraded and converted into com-
post or useful products through the use of carefully








Africa 10 8,540 0.8
Asia 152 215,992 20
Europe 152 470,860 44
America 111 296,496 27
Oceania 46 89,973 8.2
Totals 471 1,081,861
Table 2 The microbial and cell culture collections of China
Organisms held Number of strains
Algae 4,141











Total 41,288 (13,500 species)
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formulated microbial communities. Microorganisms
play an important role in soil fertility and plant health as
nitrogen ﬁxers and mycorrhizal symbionts to give plants
access to nutrients and water they would not normally
get. Microorganisms are being increasingly used in bio-
remediation of industrial waste. Through many diﬀerent
uses they can lead to poverty alleviation, for example by
production of active and marketable molecules and
through biotechnological applications. Studying the
ancestors of resistant disease organisms held in collec-
tions from times before antibiotics and some forms of
chemical pollution will help provide solutions to public
health problems.
Microorganisms have value that can be assessed in
several diﬀerent ways. At CABI Bioscience, the value of
the 28,000 strains held can be based on their replacement
cost ($12 million), the curation costs over the last
50 years ($21 million) or the revenue from sale of all
stocks ($40 million). This equates to between US$429
and US$1429 each. Microorganisms can also be valued
on the basis of cost to society and industry, for example,
up to 40% of the world rice crop is lost to pests and
diseases [http://www.riceweb.org/research/Res_isspests.
htm]. World rice production in 2002 was expected to be
384.4 million tons. worth US$ 73 billion at a cost of
US$ 190 per metric ton. A 40% loss would therefore
be valued at almost US$ 30 billion [http://www.
foodmarketexchange.com/datacenter/product/grain/rice/
detail/dc_pi_gr_rice0602_01.htm]. Microorganisms can
also be valued based upon their products, for example a
detergent enzyme raised US$ 0.5 billion in one year,
42% of sales of the 25 top-selling drugs worldwide are
either biological, natural products or entities derived
from natural products [14]. Bioremediation of soil in the
European Community in 2000 was considered to be
worth US$ 60 billion. Fungal-derived drugs are ex-
tremely valuable, for example cyclosporin raised
US$ 1.2 billion, clarithomycin, US$ 1.35 billion and
amoxicillin US$ 1.5 billion [14]. As it is not uncommon
to ﬁnd that 15–30% of fungi found in the tropics or in
unexplored environments are unknown to science, the
potential is enormous. However, biotechnology discov-
ery is not so simple. There are many diﬀerent estimates
on the chances of getting a product to market, and the
time frame can be 10–15 years. There is maybe 1 chance
in 250,000 for an unknown chemical reaching the mar-
ket; for active compounds this increases to between 1 in
5,000 to 1 in 10,000 [3]. Microbiologists can increase
chances ten-fold through manipulation of metabolism,
and chances increase when working in countries rich in
biodiversity.
The Convention on Biological Diversity
The CBD [http://www.biodiv.org] aﬀects accesses and
beneﬁt sharing for which collections can provide trans-
parency. The three key objectives of the CBD are: (1)
conservation of biodiversity; (2) sustainable development
of genetic resources; and (3) fair and equitable sharing of
resultant beneﬁts.
The CBD has been ratiﬁed by over 185 countries but
it has yet to be fully implemented, and to date few col-
lections have implemented policy to comply. Govern-
ments have not issued guidelines on access to ex situ
collections, although the Bonn Guidelines were adopted
as a voluntary code in 2002 [http://www.biodiv.org]
There have been a few case studies to attempt to develop
procedures for compliance, for example, MOSAICC and
the Common Policy Guidelines (CPG) for Botanical
Gardens, but these have been hampered by the lack of
information, e.g. on the granting of prior informed
consent (PIC), and the fact that the translation of na-
tional biodiversity strategies into action plans is not very
advanced. Countries, politicians and scientists alike are
uncertain of how to make progress without aﬀecting
scientiﬁc advancement or the environment. Tackling
compliance independently can put collections at a dis-
advantage. When CABI Bioscience introduced their
policy to ensure that material transfer agreements were
in place for all organisms supplied this resulted in a
signiﬁcant drop in the use of the collection. However,
the CBD does present an opportunity for collections
such as CABI Bioscience to help provide solutions to
some of the problems that exist.
Key requirements of the CBD
Identiﬁcation and monitoring of biodiversity (Article 7).
Ex situ conservation, preferably in-country (Article 9).
Establishment of education and training programs for
identiﬁcation, conservation and sustainable use of bio-
diversity with attention to the needs of developing
countries (Article 12). Promotion of research and the use
of scientiﬁc advances (Article 12). Access to genetic re-
sources; sovereign rights over resources is given to the
country of origin with the understanding that they will
allow access for environmentally sound use (Article 15).
Access to, and transfer of, technology—a two way ﬂow
of technology is encouraged, high technology and tax-
onomic expertise balanced with in-country traditional
knowledge (Article 16). Fair and equitable sharing of
beneﬁts on mutually agreed terms (Article 16). Exchange
of information (Article 17). Technical and scientiﬁc co-
operation (Article 18). Handling of biotechnology and
the distribution of its beneﬁts (Article 19).
Collections must work with their CBD National
Focal Points [http://www.biodiv.org] as they can pro-
vide mechanisms to help implement national policies.
Collections must organize themselves nationally in order
to play an eﬀective role and to prevent access to bio-
logical materials becoming too bureaucratic thus
impeding research and development. In the UK, the UK
National Culture Collection (UKNCC) has been formed
to co-ordinate activities of the UK national collections
as well as to develop uniform approaches to interna-
tional requirements and allow them to become more cost
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eﬀective. CABI Bioscience UK Centre runs the UKNCC
Secretariat [http://www.ukncc.co.uk]. There are over 20
national federations that can also develop enabling
mechanisms not just for the CBD but also by acting as
national nodes in many international initiatives.
Utilization of microorganisms for sustainable
development
It is clear that microorganisms do, and will continue to,
provide solutions to societal problems, and they have a
role in sustainable development. Culture collections can
play a capacity-building role to help biodiversity-rich
countries better understand and utilize their microbial
diversity. They can help initiate targeted isolation pro-
grams, aid in the characterisation of strains and establish
ex situ conservation programs to utilize preservation
technologies to retain properties and introduce modern
methodologies to add value to strains. Introducing
screening programs to collections will give biodiversity-
rich countries ownership and through partnerships allow
them to beneﬁt from exploitation of the microbial
diversity they hold. However, to achieve these ends there
is a need for collaboration.
The importance of collaboration is also exempliﬁed
by the decline in biosystematics around the world at a
time when the need to harness biodiversity to help
provide solutions to problems in the environment,
health and agriculture is at a high. Common policy for
compliance with legislation must be established, as there
are so many rules and regulations that impact on the
operations of culture collections [11]. Common policy
and practical solutions to comply are essential while
enabling the continuation of research for the beneﬁt of
humankind.
Commercialisation
Adequate funding is crucial to support culture collec-
tions, not only their continued maintenance but also
their future development [7]. There is no single model
that can be applied to the ﬁnancing of a collection.
However, a formula for sustainability must include
government support for services provided by collections
to them with respect to conservation, advancing life
science research and meeting biodiversity obligations.
Traditional products must be extended by the provision
of new products to meet the needs of today’s users, for
example, DNA, enzymes, metabolites and other deriv-
atives from authenticated strains. Collections can move
beyond this by developing commercial products through
the provision of biotechnological solutions and active
compounds, funding such initiatives through public/
private investment and the establishment of spin-oﬀ
companies. CABI Bioscience has been moving in this
direction since the 1990s, when direct UK government
funding ceased in 1989.
CABI identiﬁed the need for a rapid test kit to detect
fungal contamination in kerosene as the detection
methods of the time took 3–10 days. The company
Conidia Bioscience [http://www.conidia.com] was
established to develop the FUELSTAT resinae detection
kit, which has attracted substantial interest from aircraft
fuel providers and airlines. The use of the kit is recom-
mended in the Boeing Aircraft Maintenance Manual. It
is not beyond culture collection staﬀ to come up with
solutions to current microbial problems and to establish
similar companies whose proﬁts can be partly used to
support biosystematics, biological collections and fun-
damental research. There will be a need to develop new
products, and Conidia Bioscience plans to develop fur-
ther kits for the detection of bacteria and yeast in fuel
that can be used in storage complexes, marine vessels
and land ﬂeets. CABI Bioscience has also been involved
in developing biocontrol agents and one particular suc-
cess has been Green Muscle, used for control of African
locust [4]. Proﬁts from the sale of this product go into a
fund to support biodiversity initiatives in Africa.
Not only do collections need to ﬁnd novel ways of
funding, they also need to keep abreast of and harness
new technologies to produce information on the strains,
adding to their value with the aim of providing today’s
users with the information they need. It is not always
possible to establish these technologies in-house but it is
possible to establish partnerships with manufacturers,
other collections or institutions with the expertise and
the facilities. Bioinformatics is of increasing importance
to the operation of collections, and new ways of col-
lecting, storing, analyzing and presenting data are re-
quired to make best use of biodiversity information.
Molecular techniques to diﬀerentiate between strains
and to aid in their identiﬁcation are increasing in use.
Recent work at CABI has shown through PCR ﬁnger-
printing of replicates of an isolate of Metarhizium ani-
sopliae that polymorphisms were introduced as a result
of non-optimized preservation techniques [9]. Therefore,
at the very least collections should be adopting molec-
ular techniques to determine whether they are preserving
strains without change.
Summary
Science has moved at an extremely rapid pace since
collections ﬁrst started to maintain examples of micro-
organisms over 100 years ago [10]. The collections of
today must adapt and change to meet new demands and
they must work together to meet the enormous tasks
ahead. Lands rich in microbial diversity must explore,
maintain and utilize their genetic resources but need
human resources and technologies to do so. Capacity-
building in these areas is underway through the activities
of collections such as CABI Bioscience and through the
collection organizations such as the WFCC. How can
this be funded? As described here, microbial diversity
has enormous value; it can provide solutions to
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environmental, food and health problems and produce
high-value products. Collections must harness new
technologies and form partnerships to ﬁnd novel fund-
ing mechanisms. Ex situ microbial resource collections
have an important role to play in the conservation,
understanding and utilization of the world’s microbial
diversity.
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